Arena Pharmaceuticals Company Profile (NASDAQ:ARNA)

About Arena Pharmaceuticals

Arena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that target G protein-coupled receptors (GPCRs). The Company's drug, Lorcaserin, is approved for marketing in the United States and South Korea for the indication of weight management, and is being commercialized under the brand name, BELVIQ. The Company's drug candidates in clinical development include APD334 for autoimmune diseases, ralinepag for vascular diseases and APD371 for pain. APD334 is an orally available modulator of the sphingosine 1-phosphate subtype 1 (S1P1) receptor intended for the treatment of multiple sclerosis, psoriasis, inflammatory bowel diseases and rheumatoid arthritis. The Company's programs under collaboration include nelotanserin for dementia-associated psychosis, temanogrel for thrombotic diseases and an undisclosed orphan GPCR for central nervous system indication(s).

Industry, Sector and Symbol:

• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Exchange: NASDAQ
• Symbol: ARNA
• CUSIP: 04004710

Key Metrics:

• Previous Close: $1.77
• 50 Day Moving Average: $1.64
• 200 Day Moving Average: $1.72
• 52-Week Range: $1.30 - $2.68
• Trailing P/E Ratio: N/A
• Foreward P/E Ratio: -5.30
• P/E Growth: 0.25
• Market Cap: $425.70M
• Outstanding Shares: 243,256,000
• Beta: -0.76

Profitability:

• Net Margins: -291.35%
• Return on Equity: -226.09%
• Return on Assets: -42.15%

Debt:

• Debt-to-Equity Ratio: 4.69%
• Current Ratio: 2.56%
• Quick Ratio: 2.39%

Additional Links:

• Visit Arena Pharmaceuticals' Official Website
• View ARNA on Google Finance
• View ARNA on Yahoo Finance
• View ARNA's Company Profile on Reuters
• Search for Arena Pharmaceuticals Inc. on Google

Companies Related to Arena Pharmaceuticals:

• Cellectis SA (NASDAQ:CLLS)
• Amphastar Pharmaceuticals (NASDAQ:AMPH)
• Kindred Healthcare (NYSE:KND)
• Vascular Solutions (NASDAQ:VASC)
• Teladoc (NYSE:TDOC)
• AMAG Pharmaceuticals (NASDAQ:AMAG)
• Meridian Bioscience (NASDAQ:VIVO)
• Pacific Biosciences of California (NASDAQ:PACB)
• Merrimack Pharmaceuticals (NASDAQ:MACK)
• Retrophin (NASDAQ:RTRX)

Earnings

Earnings History for Arena Pharmaceuticals (NASDAQ:ARNA)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call	Details
11/8/2016
8/8/2016	Q216	($0.10)	($0.11)	$10.44 million	$9.50 million	View	N/A
5/9/2016	Q116	($0.10)	($0.09)	$9.02 million	$9.80 million	View	N/A
2/29/2016	Q415	($0.13)	($0.13)	$8.26 million	$7.80 million	View	N/A
11/10/2015	Q315	($0.13)	($0.11)	$8.87 million	$9.10 million	View	N/A
8/5/2015	Q215	($0.14)	($0.11)	$10.95 million	$9.18 million	View	N/A
5/11/2015	Q115	($0.14)	($0.10)	$10.56 million	$12.30 million	View	N/A
3/2/2015	Q414	($0.12)	($0.15)	$10.36 million	$9.20 million	View	N/A
11/3/2014	Q314	($0.12)	($0.05)	$10.90 million	$8.20 million	View	N/A
8/1/2014	Q2 14	($0.11)	$0.03	$9.81 million	$12.80 million	View	N/A
5/12/2014	Q114	($0.10)	($0.12)	$7.98 million	$6.80 million	View	N/A
2/27/2014	Q413	$0.02	($0.11)	$7.00 million	$6.50 million	View	N/A
11/7/2013	Q313	($0.12)	($0.08)	$5.30 million	$3.60 million	View	N/A
8/1/2013	Q2 2013	$0.15	$0.18	$57.30 million	$68.90 million	View	N/A
4/30/2013	Q1 2013	$0.11	$0.09	$50.36 million	$2.37 million	View	N/A
3/4/2013	Q4 2012	($0.03)	($0.10)	$21.94 million	$1.94 million	View	N/A
11/6/2012	Q312	($0.11)	($0.07)	$3.72 million	$1.50 million	View	N/A
8/9/2012		($0.08)	($0.12)			View	N/A
11/9/2011		($0.14)	($0.16)			View	N/A
8/9/2011		($0.15)	($0.16)			View	N/A
5/10/2011		($0.21)	($0.35)			View	N/A
3/11/2011		($0.22)	($0.23)			View	N/A

(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Arena Pharmaceuticals (NASDAQ:ARNA)

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q3 2016	1	($0.07)	($0.07)	($0.07)
Q4 2016	1	($0.07)	($0.07)	($0.07)

(Data provided by Zacks Investment Research)

Dividends

Dividend History for Arena Pharmaceuticals (NASDAQ:ARNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Arena Pharmaceuticals (NASDAQ:ARNA)

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Details
6/13/2016	Christine Anna White	Director	Sell	18,728	$1.99	$37,268.72
3/30/2015	Randall E Woods	Director	Sell	76,268	$4.49	$342,443.32
3/17/2015	Steven W Spector	EVP	Sell	70,000	$5.00	$350,000.00
1/8/2015	Steven W Spector	EVP	Sell	45,000	$6.26	$281,700.00
1/7/2015	William R Shanahan Jr	SVP	Sell	50,000	$5.49	$274,500.00
7/1/2014	Jack Lief	CEO	Sell	223,525	$5.85	$1,307,621.25
6/27/2014	Donald D Belcher	Director	Sell	2,473	$5.85	$14,467.05
5/6/2014	Donald Belcher	Director	Sell	4,176	$7.00	$29,232.00
4/22/2014	Harry Hixson, Jr.	Director	Sell	36,900	$6.31	$232,839.00
4/14/2014	Tina Susan Nova	Director	Sell	35,000	$6.22	$217,700.00
4/1/2014	Donald Belcher	Director	Sell	1,905	$6.45	$12,287.25
4/1/2014	William Shanahan, Jr.	SVP	Sell	60,000	$6.37	$382,200.00
3/4/2014	Steven Spector	EVP	Sell	25,000	$7.01	$175,250.00
1/17/2014	Jack Lief	CEO	Sell	100,000	$7.81	$781,000.00
1/10/2014	Dominic Behan	EVP	Sell	33,332	$6.25	$208,325.00
9/10/2013	Dominic P Behan	EVP	Sell	200,000	$6.31	$1,262,000.00
9/5/2013	Steven W Spector	EVP	Sell	20,000	$6.54	$130,800.00
5/21/2013	Craig Michael Audet	SVP	Sell	83,750	$8.00	$670,000.00

(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Arena Pharmaceuticals (NASDAQ:ARNA)

Date	Headline
	Watch These 5 Huge Call Purchases In Thursday Trade - Benzinga (NASDAQ:ARNA) www.benzinga.com - September 29 at 8:23 AM
	2 Sizzling Hot Biotechnology Stocks: Keryx Biopharmaceuticals Inc ... - The Independent Republic (NASDAQ:ARNA) theindependentrepublic.com - September 28 at 3:32 PM
	Active biotech company shares in the news: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Actinium Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 28 at 3:32 PM
	HC Stocks in the Rumor! Keryx Biopharmaceuticals (KERX), Arena ... - share market updates (press release) (NASDAQ:ARNA) sharemarketupdates.com - September 26 at 3:37 PM
	Biotech news that matter for investors: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Tokai Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 26 at 3:37 PM
	Active Biotech Stock News: Celgene Corporation (CELG), Arena ... - The Independent Republic (NASDAQ:ARNA) theindependentrepublic.com - September 24 at 8:53 AM
	HC Stocks Zone! Arena Pharmaceuticals, Inc. (ARNA), Opko Health ... - share market updates (press release) (NASDAQ:ARNA) sharemarketupdates.com - September 24 at 8:53 AM
	Under the Microscope, Zeroing in at Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA) www.duncanindependent.com - September 22 at 3:34 PM
	Trading the Biotech News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Dynavax Technologies Corporation ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 22 at 3:34 PM
	Biotech news that matter for investors: CytRx Corporation (NASDAQ ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 21 at 4:29 PM
	HC Stocks in the Rumor! Arena Pharmaceuticals, Inc. (ARNA), CVS Health Corp (NYSE:CVS) - share market updates (press release) (NASDAQ:ARNA) sharemarketupdates.com - September 21 at 8:32 AM
	Penny Stock Investors Take an Interest in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA) www.duncanindependent.com - September 20 at 3:35 PM
	Time To Put On The Watch List? - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Arena Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 20 at 3:35 PM
	Biotech Stocks To Put On Your Watch List: Concordia International Corp. (NASDAQ:CXRX), Arena Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 19 at 4:31 PM
	Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : September 19, 2016 (NASDAQ:ARNA) www.capitalcube.com - September 19 at 4:31 PM
	Arena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : September 19, 2016 (NASDAQ:ARNA) www.capitalcube.com - September 19 at 4:31 PM
	Arena Launches Drug Discovery Incubator (ARNA) (NASDAQ:ARNA) www.investopedia.com - September 19 at 4:31 PM
	Arena Launches Drug Discovery Incubator (ARNA) (NASDAQ:ARNA) www.investopedia.com - September 19 at 4:31 PM
	Diverse Stocks in Expert's Opinion: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Provectus Biopharmaceuticals, Inc ... - Street Wise Report (press release) (blog) (NASDAQ:ARNA) streetwisereport.com - September 19 at 8:20 AM
	HC Stocks Overview! CVS Health Corp (CVS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - share market updates (press release) (NASDAQ:ARNA) sharemarketupdates.com - September 19 at 8:20 AM
	Arena Pharmaceuticals, Inc.'s (ARNA): Market Mover - Hot Stocks Point (NASDAQ:ARNA) www.hotstockspoint.com - September 19 at 8:20 AM
	Arena Pharmaceuticals, Inc.'s (ARNA): Worth Watching Stock - Hot Stocks Point (NASDAQ:ARNA) www.hotstockspoint.com - September 16 at 3:34 PM
	Growth Analysis of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Newburg Press (NASDAQ:ARNA) newburghpress.com - September 16 at 12:16 PM
	HC Stocks Midpoint! Arena Pharmaceuticals, Inc. (ARNA), CVS Health Corp (NYSE:CVS) - share market updates (press release) (NASDAQ:ARNA) sharemarketupdates.com - September 16 at 12:16 PM
	Arena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US : September 16, 2016 (NASDAQ:ARNA) www.capitalcube.com - September 16 at 12:16 PM
	FBR Capital Initiates Coverage on Arena Pharmaceuticals, Inc. (ARNA) With An Initial Rating Of “Outperform” (NASDAQ:ARNA) www.fidaily.com - September 15 at 12:30 PM
	Coverage initiated on Arena Pharm by FBR & Co. (NASDAQ:ARNA) finance.yahoo.com - September 15 at 12:30 PM
	Analysts Valuations For Two Stocks: KB Home (NYSE:KBH), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 14 at 8:50 PM
	Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Earnings Preview ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 14 at 7:53 AM
	ETF’s with exposure to Arena Pharmaceuticals, Inc. : September 12, 2016 (NASDAQ:ARNA) www.capitalcube.com - September 12 at 3:34 PM
	How Hedge Funds Were Passing Around Marijuana Stocks in Q2 (NASDAQ:ARNA) www.insidermonkey.com - September 12 at 3:34 PM
	Time To Put On The Watch List? – Opko Health, Inc. (NASDAQ:OPK ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 10 at 8:20 AM
	News review of 2 biotech stocks: Radius Health, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 8 at 3:33 PM
	Arena Co-Founder Steps Down To Run Research Company Contracting With Arena (NASDAQ:ARNA) seekingalpha.com - September 7 at 8:43 PM
	Analysts Valuations For Two Stocks: Genworth Financial Inc (NYSE:GNW), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 7 at 12:39 PM
	Biotechnology Stocks in Focus: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD) - Post Registrar (NASDAQ:ARNA) postregistrar.com - September 7 at 12:39 PM
	Hot Biotech Stocks Recap: Arena Pharmaceuticals (NASDAQ:ARNA), PDL BioPharma (NASDAQ:PDLI) - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 6 at 3:37 PM
	Stock Struggling for the Quarter: Arena Pharmaceuticals, Inc ... - Post News (NASDAQ:ARNA) www.kentuckypostnews.com - September 4 at 3:30 PM
	Stocks Gainers/Losers Roundup- Teva Pharmaceutical Industries (TEVA), Arena Pharmaceuticals (ARNA), Tribune ... - Seneca Globe (NASDAQ:ARNA) www.senecaglobe.com - September 2 at 3:36 PM
	Shares of Cypress Semiconductor Corporation (NASDAQ:CY) & Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stocks ... - Money News (NASDAQ:ARNA) www.newsismoney.com - September 2 at 3:36 PM
	Arena Pharma (ARNA) Forms Drug Discovery Incubator 'Beacon Discovery' - StreetInsider.com (NASDAQ:ARNA) www.streetinsider.com - September 2 at 3:36 PM
	Intraday Active Biotech Stocks News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen Inc. (NASDAQ:AMGN) - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - September 2 at 3:36 PM
	Stock Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Announces Formation of Beacon Discovery - Smarter Analyst (NASDAQ:ARNA) www.smarteranalyst.com - September 2 at 8:15 AM
	4:31 pm Arena Pharm announces formation of Beacon Discovery, an independent, privately-held drug discovery incubator (NASDAQ:ARNA) finance.yahoo.com - September 2 at 8:15 AM
	Arena Pharmaceutics Announces Formation of Beacon Discovery (NASDAQ:ARNA) www.publicnow.com - September 2 at 8:15 AM
	ARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:ARNA) biz.yahoo.com - September 2 at 8:15 AM
	Taking a Serious Look at Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA) www.duncanindependent.com - August 31 at 3:34 PM
	Zeroing Our Focus on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA) www.duncanindependent.com - August 30 at 3:34 PM
	Active biotech company shares in the news: Raptor Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARNA) voiceregistrar.com - August 30 at 3:34 PM
	With Revenues Climbing, Innovus Pharma Adds Robert E. Hoffman as its Chief Financial Officer (NASDAQ:ARNA) uk.finance.yahoo.com - August 29 at 8:21 AM

Social

Arena Pharmaceuticals (NASDAQ:ARNA) Chart for Thursday, September, 29, 2016